115 related articles for article (PubMed ID: 16499092)
1. [Dihydroartemisinin inhibits the expression of vascular endothelial growth factor in K562 cells].
Li J; Zhou HJ
Yao Xue Xue Bao; 2005 Nov; 40(11):1041-5. PubMed ID: 16499092
[TBL] [Abstract][Full Text] [Related]
2. Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells.
Zhou HJ; Wang WQ; Wu GD; Lee J; Li A
Vascul Pharmacol; 2007; 47(2-3):131-8. PubMed ID: 17581794
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells.
Lee J; Zhou HJ; Wu XH
Cancer Chemother Pharmacol; 2006 Jan; 57(2):213-20. PubMed ID: 16075280
[TBL] [Abstract][Full Text] [Related]
4. [Dihydroartemisinin down-regulates the expression of transferrin receptor in myeloid leukemia cells].
Wang Z; Zhou HJ
Yao Xue Xue Bao; 2008 Jun; 43(6):576-83. PubMed ID: 18822958
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion.
Wu XH; Zhou HJ; Lee J
Anticancer Drugs; 2006 Aug; 17(7):839-48. PubMed ID: 16926633
[TBL] [Abstract][Full Text] [Related]
6. [Suppressive effect of artesunate on K562 cell growth and its influence on VEGF expression].
Lai JP; Huang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):777-80. PubMed ID: 18718059
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence.
He R; Liu B; Yang C; Yang RC; Tobelem G; Han ZC
Cancer Gene Ther; 2003 Dec; 10(12):879-86. PubMed ID: 14712314
[TBL] [Abstract][Full Text] [Related]
8. Effects and Mechanisms of Anlotinib and Dihydroartemisinin Combination Therapy in Ameliorating Malignant Biological Behavior of Gastric Cancer Cells.
Luo Q; Zhang S; Zhang D; Feng R; Li N; Chen W; Chen X; Yang S
Curr Pharm Biotechnol; 2021; 22(4):523-533. PubMed ID: 32576126
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Chen HH; Zhou HJ; Wu GD; Lou XE
Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
[TBL] [Abstract][Full Text] [Related]
10. [Dihydroartemisinin inhibits proliferation and induces apoptosis of rat glioma C6 cells].
Ma ZQ; Huang XJ; Zhang WP
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 May; 36(3):267-72. PubMed ID: 17571310
[TBL] [Abstract][Full Text] [Related]
11. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis.
Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L
Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis.
Dong F; Zhou X; Li C; Yan S; Deng X; Cao Z; Li L; Tang B; Allen TD; Liu J
Cancer Biol Ther; 2014; 15(11):1479-88. PubMed ID: 25482945
[TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin inhibits angiogenesis in breast cancer via regulating VEGF and MMP-2/-9.
Rao Q; Yu H; Li R; He B; Wang Y; Guo X; Zhao G; Wu F
Fundam Clin Pharmacol; 2024 Feb; 38(1):113-125. PubMed ID: 37490927
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of leukemic cell proliferation by human soluble VEGF-R1].
Zhu J; Song YQ; Li W; Wang GJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):168-74. PubMed ID: 17490547
[TBL] [Abstract][Full Text] [Related]
15. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
[TBL] [Abstract][Full Text] [Related]
16. Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.
M HR; Ghosh D; Banerjee R; Salimath BP
Pharm Biol; 2017 Dec; 55(1):1489-1499. PubMed ID: 28367666
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial dihydroartemisinin also inhibits angiogenesis.
Chen HH; Zhou HJ; Wang WQ; Wu GD
Cancer Chemother Pharmacol; 2004 May; 53(5):423-32. PubMed ID: 15132130
[TBL] [Abstract][Full Text] [Related]
18. Fluocinolone inhibits VEGF expression via glucocorticoid receptor in human retinal pigment epithelial (ARPE-19) cells and TNF-alpha-induced angiogenesis in chick chorioallantoic membrane (CAM).
Ayalasomayajula SP; Ashton P; Kompella UB
J Ocul Pharmacol Ther; 2009 Apr; 25(2):97-103. PubMed ID: 19284324
[TBL] [Abstract][Full Text] [Related]
19. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway.
Wang SJ; Sun B; Cheng ZX; Zhou HX; Gao Y; Kong R; Chen H; Jiang HC; Pan SH; Xue DB; Bai XW
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1421-30. PubMed ID: 21479633
[TBL] [Abstract][Full Text] [Related]
20. Artesunate reduces chicken chorioallantoic membrane neovascularisation and exhibits antiangiogenic and apoptotic activity on human microvascular dermal endothelial cell.
Huan-huan C; Li-Li Y; Shang-Bin L
Cancer Lett; 2004 Aug; 211(2):163-73. PubMed ID: 15219940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
